Hormone replacement therapy in women with past history of endometriosis

References

• Olive D L, Schwartz L B. Endometriosis. N Engl J Med 1993; 328: 1759–1769
   PubMed Web of Science ®Google Scholar
• Kempers R D, Dockerty M B, Hunt A B, et al. Significant postmenopausal endometriosis. Surg Gynaecol Oncol 1960; 111: 348–356
   PubMedGoogle Scholar
• Punnonen R, Klemi P J, Nikkanen U. Postmenopausal endometriosis. Eur J Obstet Gynaecol Reprod Biol 1980; 11: 195–200
   PubMed Web of Science ®Google Scholar
• Antunes C MF, Stolley P D, Ronenstein M B, et al. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med 1979; 300: 9–13
   PubMed Web of Science ®Google Scholar
• Nisolle M, Casenas-Roux F, Wynns C, et al. Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: a new quantitative method. Fertil Steril 1994; 62: 751–759
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Ferno M. Estrogen and progesterone receptors in endometriotic tissue and endo metrium: comparison according to localization and recurrence. Fertil Steril 1993; 60: 63–68
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cyclic phases and stages. Hum Reprod 1993; 8: 2211–2217
   PubMed Web of Science ®Google Scholar
• Barbieri R L. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992; 166: 740–745
   PubMed Web of Science ®Google Scholar
• Matorras R, Elorriaga M A, Pijoan J I, et al. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril 2002; 77: 303–308
   PubMed Web of Science ®Google Scholar
• Namnoum A B, Hickman T N, Goodman S B, et al. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril 1995; 64: 898–902
   PubMed Web of Science ®Google Scholar
• Schor E, Baracat E C, Simeos M J, et al. Effects of conjugated estrogen and progestogen in surgically induced endometriosis in oophorectomized rats. Clin Exp Obstet Gynaecol 1999; 26: 158–161
   PubMedGoogle Scholar
• Lam A M, French M, Charnock F M. Bilateral ureteric obstruction due to recurrent endometriosis associated with hormone replacement therapy. Aust NZ Obstet Gynaecol 1992; 32: 83–84
   PubMed Web of Science ®Google Scholar
• Moore J G, Hibbard L T, Growdon W A, et al. Urinary tract endometriosis: incidence and management. Am J Obstet Gynecol 1979; 134: 162–172
   PubMed Web of Science ®Google Scholar
• Sampson J A. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925; 10: 1–72
   Google Scholar
• Berguld A S, Sparen P, Bergqvist A. Endometriosis and the risk of cancer. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, 2003. Hum Reprod 2003; 18: 80
   Google Scholar
• Varma R, Rollason T, Gupta J K, et al. Endometriosis and the neoplastic process. Reproduction 2004; 127: 293–304
   PubMed Web of Science ®Google Scholar
• Brooks J J, Wheeler J E. Malignancy arising in extragonadal endometriosis. A case report and summary of the literature. Cancer 1977; 40: 3065–3073
   PubMed Web of Science ®Google Scholar
• Lauslahti K. Malignant external endometriosis. A case of adenocarcinoma of umbilical endometriosis. Acta Pathol Microbiol Scand A 1972; 80(Suppl 223)98–102
   Google Scholar
• Reintoft I, Lange A, Skipper A. Coincidence of granulosa cell tumour of ovary and development of carcinoma in rectal endometriosis. Acta Obstet Gynecol Scand 1974; 53: 185–189
   PubMed Web of Science ®Google Scholar
• Cohen I, Altaras M M, Lew S, et al. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of literature. Gynecol Oncol 1994; 55: 443–447
   PubMed Web of Science ®Google Scholar
• Debus G, Schumacher I. Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report. Acta Obstet Gynaecol Scand 2001; 80: 589
   PubMed Web of Science ®Google Scholar
• Brinton L A, Gridley G, Perrson I, et al. Cancer risk after hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176: 572–579
   PubMed Web of Science ®Google Scholar
• Zanetta G M, Webb J M, Li H, et al. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 2000; 79: 18–22
   PubMed Web of Science ®Google Scholar
• Heaps J M, Neiberg R K, Berek J S. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75: 1023–2
   PubMed Web of Science ®Google Scholar
• Young E, Gamble C. Primary adenocarcinoma of the rectovaginal septum arising from endometriosis. Report of a case. Cancer 1969; 24: 597–601
   PubMed Web of Science ®Google Scholar
• Lott J V, Rubin R J, Salvati E P, et al. Endometrioid carcinoma of the rectum arising in endometriosis. Report of a case. Dis Col Rectum 1978; 21: 56–60
   PubMed Web of Science ®Google Scholar
• Granai C O, Walters M D, Safaii H, et al. Malignant transformation of vaginal endometriosis. Obstet Gynecol 1984; 64: 592–595
   PubMed Web of Science ®Google Scholar
• Orr J W, Holimon J L, Sission P F. Vaginal adenocarcinoma developing in residual pelvic endometriosis: a clinical dilemma. Gynecol Oncol 1989; 33: 96–98
   PubMed Web of Science ®Google Scholar
• Kapp D S, Merino M, LiVolsi V. Case reports: adenocarcinoma of the vagina developing in endometriosis; long term survival following radiation therapy. Gynecol Oncol 1982; 14: 271–278
   PubMed Web of Science ®Google Scholar
• Berkowitz R S, Ehmann R L, Knapp R C. Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol 1978; 51: 34–37
   Web of Science ®Google Scholar
• Remnitz C, Brand E, Neiberg R K, et al. Malignancy arising in endometriosis associated with unopposed estrogen replacement. Obstet Gynecol 1988; 1: 444–447
   Google Scholar
• Brunson G L, Barclay D I, Sanders M, et al. Malignant extraovarian endometriosis: two case reports and review of the literature. Gynecol Oncol 1988; 30: 123–130
   PubMed Web of Science ®Google Scholar
• McCluggage W G, Bailie C, Weir P, et al. Endometrial stromal sarcoma arising in pelvic endometriosis in a patient receiving unopposed oestrogen therapy. Br J Obstet Gynaecol 1996; 103: 1252–1254
   PubMedGoogle Scholar
• Shamsuddin A KM, Villa Santa U, Tang C K, et al. Adenocarcinoma arising from extragonadal endometriosis 14 years after total hysterectomy and bilateral salpingo-oophorectomy for endometriosis: Report of a case with ultrastructural studies. Am J Obstet Gynecol 1979; 133: 585–586
   PubMed Web of Science ®Google Scholar
• Dunn S, Boed-Petersen K, Michelsen J W. Endometrioid carcinoma arising from endometriosis of the sigmoid colon during estrogenic treatment. Acta Obstet Gynecol Scand 1993; 72: 676–678
   PubMed Web of Science ®Google Scholar
• Sidhu S, Rainer E S, O'Connor T O. Extraovarian endometrioid carcinoma associated with unopposed oestrogen replacement therapy. Aust NZ J Obstet Gynaecol 1998; 38: 125–127
   PubMed Web of Science ®Google Scholar
• Abu M AE, Sinha P, Totoe L, et al. Endometrial cancer thirteen years after total abdominal hysterectomy and bilateral salpingo-oophorectomy and hormone replacement therapy: a case report. Eur J Gynecol Oncol 1997; 18: 482–483
   PubMed Web of Science ®Google Scholar
• Taylor M, Bowen-Simpkins P, Barrington J. Complications of unopposed oestrogen following radical surgery. Gynaecology 1999; 19: 647–648
   Google Scholar
• Jimenez R E, Tiguert R, Hurley P, et al. Unilateral hydronephrosis resulting from intramural obstruction of the ureter by adenosquamous endometrioid carcinoma arising from disseminated endometriosis. Urology 2000; 56: 331
   PubMedGoogle Scholar
• Powell J L, Conor P, Henderson G S. Androgen-producing, atypically proliferating endometrioid tumour arising in endometriosis. South Med J 2001; 94: 450–453
   PubMed Web of Science ®Google Scholar
• Larvey S, Gillmer M. Malignant transformation of residual endometriosis in women on unopposed oestrogen hormone replacement therapy. Br J Obstet Gynaecol 2001; 108: 1106–1107
   Google Scholar
• Jones K D, Owen E, Berresford A, et al. Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon. Gynecol Oncol 2002; 86: 220–222
   PubMed Web of Science ®Google Scholar
• Areia A, Sousa V, Frutuoso C, et al. Endometrioid adenocarcinoma in endometriosis foci six years after estrogen replacement therapy: a case report. Eur J Gynaecol Oncol 2004; 25: 225–226
   PubMed Web of Science ®Google Scholar
• Soliman N F, Evans A J. Malignancy arising in residual endometriosis following hysterectomy and hormone replacement therapy. J Br Menop Soc 2004; 10: 123–124
   PubMedGoogle Scholar
• Chang H Y, Changchien C C, Chen H H, et al. Extrauterine mullerian adenocarcinoma associated with endometriosis and rectal villotubular adenoma: report and a case and review of the literature. Int J Gynecol Cancer 2005; 15: 361–365
   PubMed Web of Science ®Google Scholar
• Somoye G O, Gull S. Adenocarcinoma of the vaginal vault following prolonged unopposed oestrogen replacement therapy. J Obstet Gynaecol 2005; 25: 220–221
   PubMedGoogle Scholar
• Kawate S, Takeyoshi I, Ikota H, et al. Endometrioid adenocarcinoma arising from endometriosis of the mesentrium of the sigmoid colon. Jpn J Clin Oncol 2005; 35: 154–157
   PubMed Web of Science ®Google Scholar
• Salerno M G, Masciullo V, Naldini A, et al. Endometrioid adenocarcinoma with squamous differentiation arising from uretral endometriosis in a patient with no history of gonadal endometriosis. Gynecol Oncol 2005; 99: 749–752
   PubMed Web of Science ®Google Scholar
• Milsom I, Molander U. Urogenital ageing. J Br Menop Soc 1998; 4: 151–156
   Google Scholar
• Nathorst-Boos J, Von Schoultz H. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynaecol Obstet Invest 1992; 34: 97–101
   PubMed Web of Science ®Google Scholar
• Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med 1995; 98(1A)76–95
   PubMed Web of Science ®Google Scholar
• Van der Schow Y T, Van der Graaf Y, Steyerberg E W, et al. Age at menopause as a risk factor for cardiovascular morbidity. Lancet 1996; 347: 714–718
   PubMed Web of Science ®Google Scholar
• Kalantaridou S N, Naka K K, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. Clin Endocrinol Metab 2004; 89: 3907–3913
   Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized trial. JAMA 2004; 291: 1701–1712
   PubMed Web of Science ®Google Scholar
• Managing the menopause. BMS Council Consensus statement on HRT. J Br Menop Soc 2004; 10: 33–36
   PubMedGoogle Scholar
• Hormone replacement therapy (HRT): Latest safety update (updated 3 December 2003). CSM statement. www.mhra.gov.uk/home/groups/pl-p/ documents/drugsafetymessage/con019499.pdf (last accessed 17/03/06)
   Google Scholar
• Addison W A, Hammond C B, Parker R T. The occurrence of adenocarcinoma in endometriosis of the rectovaginal septum during progestational therapy. Gynecol Oncol 1979; 8: 193–197
   PubMed Web of Science ®Google Scholar
• Pokieser R, Schmerker R, Kisser M, et al. Clear cell carcinoma arising in endometriosis of the rectum following progestin therapy. Pathol Res Pract 2002; 198: 121–124
   PubMed Web of Science ®Google Scholar
• Moghissi K S, Schlaff W D, Olive D L, et al. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril 1998; 69: 1056–1062
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Raffaelli R, et al. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas 1999; 32: 189–193
   PubMed Web of Science ®Google Scholar
• Beral V, Bull D, Reaves G, Million Women Study Collaborators. Endometrial cancer and hormone replacement therapy. The Million Women Study. Lancet 2005; 30: 1543–1551
   Google Scholar
• Henderson A F, Studd J WW. The role of definitive surgery and hormone replacement therapy in the treatment of endometriosis. Modern Approaches to Endometriosis, E Thomas, J Rock. Kluwer Academic Publishers, London 1991; 275–290
   Google Scholar
• Zhou J, Ng S, Adesanya-Famuiya O, et al. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 2000; 14: 1725–1730
   PubMed Web of Science ®Google Scholar
• Davis S R, McCloud P I, Strauss B JG, et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227–236
   PubMed Web of Science ®Google Scholar
• Hickman T M, Namnoum A B, Hinton E L, et al. Timing of estrogen replacement therapy following hysterectomy with oophorectomy for endometriosis. Obstet Gynecol 1998; 91: 673–677
   PubMed Web of Science ®Google Scholar
• Gargett C E. Stem cells in gynaecology. Aust NZ J Obstet Gynaecol 2004; 44: 380–386
   PubMed Web of Science ®Google Scholar